Complex relationship of obesity and obesity paradox in heart failure–higher risk of developing heart failure and better outcomes in established heart failure

Annals of Medicine

Volumn 48, Issue 8, 2016, Pages 603-613

  Alagiakrishnan, Kannayiram ^a   Banach, Maciej ^b   Ahmed, Ali ^c   Aronow, Wilbert S ^d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Heart failure; mortality; obesity; obesity paradox; obesity phenotypes

Indexed keywords

ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; LEPTIN; LIPOPOLYSACCHARIDE; LIPOPROTEIN; RESISTIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; CLINICAL OUTCOME; DISEASE MARKER; EMBASE; HEART FAILURE; HUMAN; LEAN BODY WEIGHT; MALNUTRITION; MEDLINE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; OBESITY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SARCOPENIC OBESITY; SCOPUS; SYSTEMATIC REVIEW; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ADIPOSE TISSUE; FEMALE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS;

ADIPOSE TISSUE; BODY COMPOSITION; BODY MASS INDEX; FEMALE; HEART FAILURE; HUMANS; MALE; OBESITY; PROGNOSIS; RISK ASSESSMENT;

EID: 84978543492     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.1080/07853890.2016.1197415     Document Type: Review

References (88)

1. Baena-Diez JM, Bynan AO, Grau M, Gornez-Fernandez C, Vidal-Solsona M, Ledesma-Ulloa G, et al. Obesity is an independent risk factor for heart failure:Zona Franca Cohort study. Clin Cardiol. 2010;33:760–4.
2. Nicklas BJ, Lesari M, Penninx BW, Kritchevsky SB, Ding J, Newman A, et al. Abdominal obesity is an independent risk factor for chronic heart failure in older people. J Am Geriatr Soc. 2006;54:413–20.
3. World Health Organization. Obesity and overweight; 2013. Available from:http://www.who.int.login.ezproxy.library.ualberta.ca/mediacentre/factsheets/fs311/en/
4. Alpert MA, Lavie CJ, Agarwal H, Aggarwal K, Kumar SA., Obesity and heart failure. Epidemiology, pathophysiology, clinical manifestations and management. Trans Res. 2014;164:345–56.
5. Lavie CJ, Alpert Ma Arena R, Mehra MR, Milani RV, Ventura HO. Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail. 2013;1:93–102.
6. Alagiakrishnan K, Banach M, Jones LG, Ahmed A, Aronow WS., Medication management of chronic heart failure in older adults. Drugs Aging. 2013;30:765–82.
7. Metra M, Dei Cas L, Massie BM. Treatment of heart failure in the elderly:never say it's too late. Eur Heart J. 2009;30:391–3.
8. Patel K, Sui X, Zhang Y, Fonarow CC, Aban IB, Brown CJ, et al. Prevention of heart failure in older adults may require higher levels of physical activity than needed for other cardiovascular events. Int J Cardiol. 2013;168:1905–9.
9. Alagiakrishnan K, Banach M, Jones LG, Datta S, Ahmed A, Aronow WS., Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults. Ann Med. 2013;45:37–50.
10. Hobbs FD, Roalfe AK, Davis RC, Davies MK, Hare R., Midland Research practices Consortium (MidReC). Prognosis of all-cause heart failure and borderline left ventricular systolic function:5-year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES). Eur Heart J. 2007;28:1128–34.
11. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:305–13.
12. Kenchaiah S, Sesso HD, Gaziono JM., Body mass index and vigorous physical activity and the risk of heart failure among men. Circulation. 2009;119:44–52.
13. Owan TE, Hudge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM., Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–9.
14. Flegal KN, Kalantar-Zadeh K., Overweight, mortality and survival. Obesity (Silver Spring). 2013;21:1744–5.
15. Pozzo J, Fourner P, Lairez O, Velvueren PL, Delmas C, Elbaz M, et al. Obesity paradox:origin and best way to assess severity in patients with systolic HF. Obesity (Silver Spring). 2015;23:2002–8.
16. Clark AL, Fonarow GC, Horwich TB. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis. 2013;56:409–14.
17. Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC., Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004;43:1439–44.
18. Horwich TB, Hernandez AF, Dai D, Yancy CW, Fonarow GC. Cholesterol levels and in-hospital mortality in patients with acute decompensated heart failure. Am Heart J. 2008;156:1170–6.
19. Horwich TB, Hamilton MA, MacLellan WR, Fonarow GC., Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail. 2002;8:216–24.
20. Sakatani T, Shirayama T, Suzaki Y, Yamamoto T, Mani H, Kawasaki T, et al. The association between cholesterol and mortality in heart failure. Comparison between patients with and without coronary artery disease. Int Heart J. 2005;46:619–29.
21. Christ M, Klima T, Grimm W, Mueller HH, Maisch B., Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy. Eur Heart J. 2006;27:691–9.
22. Lissin LW, Gauri AJ, Froelicher VF, Ghayourmi A, Myers J, Glacommini J., The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure. J Card Fail. 2002;8:206–15.
23. Vest AR, Wu Y, Hachamovitch R, Young JB, Cho L. The Heart Failure overweight/obesity survival Paradox:the missing sex link. JACC Heart Fail. 2015;3:917–26.
24. Oreopoulos A, Ezekowitz JA, Mc Alister FA, Kalantar-Zadeh K, Fonarow GC, Norris CM, et al. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc. 2010;85:609–17.
25. Prado CM, Gonzalez MC, Heymsfield SB., Body composition phenotypes and obesity paradox. Curr Opin Clin Nutr Metab Care. 2015;18:535–51.
26. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hanners L, Macinnis RJ, et al. Body mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211.
27. Pandey A, Berry JD, Lavie CJ., Cardiometabolic disease leading to heart failure:better fat and fit than lean and lazy. Curr Heart Fail Rep. 2015;12:302–8.
28. Aune D, Sen A, Norat T, Janszky I, Romundstad P, Tonstad S, et al. Body mass index, abdominal fitness and heart failure incidence and mortality. A systematic review and dose-response meta-analysis of prospective studies. Circulation. 2016;133:639–49.
29. Colin-Ramirez E, Orea-Tejeda A, Castillo-Martinez L, Montano- Hernandez P, Sanchez -Ramirez A, Pineda- Juarez JA, et al. Malnutrition syndrome, but not body mass index is associated with worse prognosis in heart failure patients. Clin Nutr. 2011;30:753–8.
30. Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallager D, Morley JE. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004;12:1995–2004.
31. Clark AL, Fonarow GC, Horwich TB., Waist circumference, body mass index, and survival in systolic heart failure:the obesity paradox revisited. J Card Fail. 2011;17:374–80.
32. Gastelurritia P, Lupon J, de Antonio M, Zamora E, Domingo M, Urrulia A, et al. Body mass index, body fat and nutritional status of patients with heart failure:the PLICA study. Clin Nutr. 2015;34:1233–8.
33. Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, Wruck LM, et al. Pre-morbid body mass index and mortality after incident heart failure. The ARIC study. J Am Coll Cardiol. 2014;64:2743–9.
34. Abel ED, Litwin SE, Sweeney G. Cardiac remodeling in obesity. Physiol Rev. 2008;88:389–419.
35. Perseghin G, Ntali G, De Cobelli F, Lattuada G, Esposito A, Belloni E, et al. Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance. Diabetes Care. 2007;30:1520–6.
36. Tamaki S, Mano T, Sakata Y, Ohtani T, Takeda Y, Kamimura D, et al. Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction. PLoS One. 2013;8:e68893.
37. Szczepaniak LS, Victor RG, Orci L, Unger RH., Forgotten but not gone:the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res. 2007;101:759–67.
38. Creopoulos A, Kalantar-Zadeh K, Sharma AM, Fonarow GC. The obesity paradox in the elderly:potential mechanisms and clinical implications. Clin Geriatr Med. 2009;25:643–59.
39. Lavie CJ, Romero-Corral A. Body composition and heart failure prevalence and prognosis:getting to the fat of the matter in the “obesity paradox”. Mayo Clin Proc. 2010;85:605e8.
40. Arena R, Lavie CJ., The obesity paradox and outcome in heart failure:is excess bodyweight truly protective? Future Cardiol. 2010;6:1–6.
41. Dorner TE, Rieder A., Obesity paradox in elderly patients with cardiovascular diseases. Int J Cardiol. 2012;155:56–65.
42. Clerico A, Gionnoni A, Vittorini S, Emdin M., The paradox of low BNP levels in obesity. Heart Fail Rev. 2012;17:81–96.
43. McGaffin KR, Moravec CS, Mctiernan CF. Leptin signaling in the failing and mechanically unloaded human heart. Circ Heart Fail. 2009;2:676–83.
44. Kistorp C, Faber J, Galatus S, Gustafsson F, Frystyk J, Flyybjerg A, et al. Plasma adiponectin, body mass index and mortality in patients with chronic heart failure. Circulation. 2005;112:1756–62.
45. Sethi JK. Activatin' human adipose progenitors in obesity. Diabetes. 2010;59:2354–7.
46. Beaufrere B, Morio B., Fat and protein distribution with aging. Metabolic considerations. Eur J Clin Nutr. 2000;54:548–53.
47. Horani MH, Mooradian AD., Management of obesity in the elderly:special considerations. Treat Endocrinol. 2002;1:387–98.
48. Roubenoff R., Sarcopenic obesity:the confluence of two epidemics. Obes Res. 2004;12:887–8.
49. Tucato E, Bosello O, Di Francesco V, Harris TB, Zoico E, Bissoli L, et al. Waist circumference and abdominal sagittal diameter as surrogates of body fat distribution in the elderly:their relation with cardiovascular risk factors. Int J Obes Relat Metab Disord. 2000;24:1005–10.
50. Visscher TL, Seidell JC, Molarius A, van der Kuip D, Hofman A, Witteman JC. A comparison of body mass index, waist–hip ratio and waist circumference as predictors of all-cause mortality among the elderly:the Rotterdam study. Int J Obes Relat Metab Disord. 2001;25:1730–5.
51. De schutter A, Lavie CJ, Kachur S, Patel DA, Milani RV., Body composition and mortality in a large cohort with preserved ejection fraction:untangling the obesity paradox. Mayo Clin Proc. 2014;89:1072–9.
52. Clark AL, Chyu J, Horwich TB., The obesity paradox in men versus women with systolic heart failure. Am J Cardiol. 2012;110:77–82.
53. Chumlea WC, Guo SS, Kuczmarski RJ, Flegal KM, Johnsol CL, Heymsfield SB, et al. Body composition estimates from NHANES III bioelectrical impedance data. Int J Obes Relat Metab Disord. 2002;26:1596–609.
54. Bozorgmanesh M, Hadaegh F, Khalili D, Azizi F., Prognostic significance of the complex “Visceral Adiposity Index” US simple anthropometric measures:Tehran lipid and glucose study. Cardiovasc Diabetol. 2012;11:20.
55. Baumgartner RM, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755–63.
56. Janssen I. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004;159:413–21.
57. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia:European consensus on definition and diagnosis:report of the European working group on sarcopenia in older people. Age Ageing. 2010;39:412–23.
58. World Health Organization. Obesity:preventing and managing the global epidemic. Geneva, Switzerland:World Health Organization, 2000. Technical report 894.
59. Sharma A, Lavie CJ, Borer JS, Vallakali A, Goel S, Lopez-Jinemez F, et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol. 2015;15:1428–34.
60. Lavie CJ, Sharma A, Alpert Ma De Schutter A, Lopez-Jimenez F, Milani RV, Ventura HO., Update on obesity and obesity paradox in heart Failure. Prog Cardiovasc Dis. 2015;58:393–400.
61. Kamiya K, Masuda T, Matsue Y, Inomata T, Hamazaki N, Matsuzawa R, et al. Complementary role of arm circumference to body mass index in risk stratification in heart failure. JACC Heart Fail. 2016;4:265–73.
62. Batsis JA, Mackenzie TA, Barre LK, Lopez J, Bartels SJ., Sarcopenia, sarcopenic obesity and mortality in older adults:results from the National Health and Nutrition Examination Survey III. Eur J Clin Nutr. 2014;68:1001–7.
63. Kitzman DW, Nicklas B, Kraus WE, Lyles MF, Eggebeen J, Morgan TM, et al. Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction. Am J Physiol Heart Circ Physiol. 2014;306:H1364–70.
64. Stephen WC, Janssen I., Sarcopenic obesity and cardiovascular disease risk in the elderly. J Nutr Health Aging. 2009;13:460–6.
65. Wannamethee SG, Shaper AG, Whineup PH, Lennon L, Papacosta O, Sattar N., The obesity paradox in men with coronary heart disease and heart failure:the role of muscle mass and leptin. Int J Cardiol. 2014;171:49–55.
66. Anker MS, von Haehling S, Springer J, Banach M, Anker SD., Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Arch Med Sci. 2013;9:166–71.
67. Bluher M., The distinction of metabolically healthy from unhealthy obese individuals. Curr Opin Lipidol. 2010;21:38–43.
68. Ortega FB, Lee D, Katzmarezyk PT, Ruiz JR, Sui X, Church TS, et al. The intriguing metabolically healthy but obese phenotype:cardiovascular prognosis and role of fitness. Eur Heart J. 2013;34:389–97.
69. Karelis AD., To be obese–does it matter if you are metabolically healthy? Nat Rev Endocrinol. 2011;7:699–700.
70. Waldman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering:prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008;168:1617–24.
71. Voulgari C, Tentolouris N, Dilaveris P, Tousolis D, Katsilambros N, Stefanadis C., Increased heart failure risk in normal weight people with metabolic syndrome compared with metabolically healthy obese individuals. J Am Coll Cardiol. 2011;58:1343–50.
72. Stefan N, Harring HU, Hu FB, Schulze MB., Metabolically healthy obesity:epidemiology, mechanisms and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152–62.
73. Arsenault BJ, Beaumont EP, Despres JP, Larose E., Mapping body fat distribution:a key step towards the identification of the vulnerable patient? Ann Med. 2012;44:758–72.
74. Dobson R, Burgess MI, Sprung VS, Irwin A, Hamer M, Jones I, et al. Metabolically healthy and unhealthy obesity. Differential effects on myocardial function according to metabolic syndrome, rather than obesity. Int J Obes. 2010;40:153–61.
75. Shaharyar S, Roberson LL, Jamal O, Younus A, Blaha MJ, Ali SS, et al. obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are sensitivity associated with prevalence of elevated C-reactive protein and hepatic steatosis in a large healthy Brazilian population. J Obes. 2015;2015:178526.
76. Morkedal B, Vatten LJ, Romundstad PR, Laugsand LE, Janszky I., Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals:HUNT (NORD-Trondelag Health Study) Norway. J Am Coll Cardiol. 2014;63:1071–8.
77. Berry JD, Pandey A, Gao A, Leonard D, Farzaneh-Far A, Ayers C, et al. Physical fitness and risk for heart failure and coronary artery disease. Circ Heart Fail. 2013;6:627–34.
78. Cornwell WNI, Pandey A, Wilis B, leonard D, Gao A, Defina L, et al. Combined association of midlife obesity and fitness with long-term risk of heart failure–the cooper center longitudinal study. Circulation. 2013;128:A 15669.
79. Pandey A, Patel M, Gao A, Willis BL, Das LR, Leonard D, et al. Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and non-cardiac risk factors:the Cooper Center Longitudinal Study. Am Heart J. 2015;169:290–7.
80. Barry VW, Baruth M, Beets MW, Durstine JL, Liu J, Blair SN. Fitness vs. fatness on all-cause mortality:a meta-analysis. Prog Cardiovasc Dis. 2014;56:382–90.
81. McAuley PA, Bevers KM., Contribution of cardiorespiratory fitness to the obesity paradox. Prog Cardiovasc Dis. 2014;56:434–40.
82. Lee DC, Sui X, Artero EG, Lee IM, Church TS, McAuley PA, et al. Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men:the Aerobics Center Longitudinal Study. Circulation. 2011;124:2483–90.
83. Lavie CJ, Cahalin LP, Chase P, Myers J, Bensimhon D, Peberdy MA, et al. Impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin Proc. 2013;88:251–8.
84. Clark AL, Fonarow GC, Horwich TB., Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic heart failure. Am J Cardiol. 2015;115:209–13.
85. Shetty PM, Hauptman PJ, Landfried LK, Patel K, Weiss EP., Micronutrient deficiencies in patients with heart failure:relationships with body mass index and age. J Card Fail. 2015;21:968–72.
86. Casas-Vara A, Santolaria F, Fernandez-Bereciartua A, Gonzalez-Reimers E, Garcia-Ochoa A, Martinez-Riera A., The obesity paradox in elderly patients with heart failure:analysis of nutritional status. Nutrition. 2012;28:616–22.
87. Adejumo OL, Koeling TM, Hummel SL. Nutritional Risk Index predicts mortality in hospitalized advanced heart failure patients. J Heart Lung Transplant. 2015;34:1385–9.
88. Orepoulos A, Padwal R, Kalantar-Zadeh K, Fonarow CC, Norris CM, Mc Alister FA., Body mass index and mortality in heart failure:a meta-analysis. Am Heart J. 2008;156:13–22.